Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Graham

Showing results (841-850 of 968) with videos related to

Pageof 97
Sort By:
Blood|July 18, 2013
Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemiaRachel M A Linger, Alisa B Lee-Sherick, Deborah DeRyckere, et al.
The International Journal of Eating Disorders|July 4, 2019
Screening and offering online programs for eating disorders: Reach, pathology, and differences across eating disorder status groups at 28 U.S. universitiesEllen E Fitzsimmons-Craft, Katherine N Balantekin, Dawn M Eichen, et al.
Oncogene|August 15, 2012
Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancerR M A Linger, R A Cohen, C T Cummings, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
A transition zone enriched <i>WIF1</i> ⁺ basal cell subtype is associated with benign prostatic hyperplasiaRulin Wang, Qizhi Zheng, Mindy K Graham, et al.
Eating Behaviors|February 20, 2021
Overweight and obesity are associated with increased eating disorder correlates and general psychopathology in university women with eating disordersKatherine N Balantekin, Anne Claire Grammer, Ellen E Fitzsimmons-Craft, et al.
European Journal of Medicinal Chemistry|April 4, 2025
Exploiting structural variability in the kinase back-pocket to modulate polypharmacology of TAM inhibitorsMegan D Hopkins, Dehui Zhang, Zhilong Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2014
Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbationsFrancesca Alvarez-Calderon, Mark A Gregory, Catherine Pham-Danis, et al.
Molecular Cancer Research : MCR|October 16, 2019
Functional Loss of <i>ATRX</i> and <i>TERC</i> Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer CellsMindy K Graham, Jiyoung Kim, Joseph Da, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia ModelsDeborah DeRyckere, Alisa B Lee-Sherick, Madeline G Huey, et al.
The Journal of Biological Chemistry|October 18, 2000
Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib)M W Ritzel, A M Ng, S Y Yao, et al.
Pageof 97

Showing results (841-850 of 968) with videos related to

Sort By:
Pageof 97
Blood|July 18, 2013
Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemiaRachel M A Linger, Alisa B Lee-Sherick, Deborah DeRyckere, et al.
The International Journal of Eating Disorders|July 4, 2019
Screening and offering online programs for eating disorders: Reach, pathology, and differences across eating disorder status groups at 28 U.S. universitiesEllen E Fitzsimmons-Craft, Katherine N Balantekin, Dawn M Eichen, et al.
Oncogene|August 15, 2012
Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancerR M A Linger, R A Cohen, C T Cummings, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
A transition zone enriched <i>WIF1</i> ⁺ basal cell subtype is associated with benign prostatic hyperplasiaRulin Wang, Qizhi Zheng, Mindy K Graham, et al.
Eating Behaviors|February 20, 2021
Overweight and obesity are associated with increased eating disorder correlates and general psychopathology in university women with eating disordersKatherine N Balantekin, Anne Claire Grammer, Ellen E Fitzsimmons-Craft, et al.
European Journal of Medicinal Chemistry|April 4, 2025
Exploiting structural variability in the kinase back-pocket to modulate polypharmacology of TAM inhibitorsMegan D Hopkins, Dehui Zhang, Zhilong Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 31, 2014
Tyrosine kinase inhibition in leukemia induces an altered metabolic state sensitive to mitochondrial perturbationsFrancesca Alvarez-Calderon, Mark A Gregory, Catherine Pham-Danis, et al.
Molecular Cancer Research : MCR|October 16, 2019
Functional Loss of <i>ATRX</i> and <i>TERC</i> Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer CellsMindy K Graham, Jiyoung Kim, Joseph Da, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia ModelsDeborah DeRyckere, Alisa B Lee-Sherick, Madeline G Huey, et al.
The Journal of Biological Chemistry|October 18, 2000
Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib)M W Ritzel, A M Ng, S Y Yao, et al.
Pageof 97